Skip to main content


Fig. 1 | BMC Cell Biology

Fig. 1

From: Post-treatment de-phosphorylation of p53 correlates with dasatinib responsiveness in malignant melanoma

Fig. 1

Heterogeneous growth arrest in melanoma cells treated with dasatinib, alone or in combination with dacarbazine. a Cell proliferation (cell count) of melanoma cell lines after single and combination treatment with dasatinib and dacarbazine (72 h). Bars represent mean values of percentage change normalized to the control. Data are from three independent experiments, each run with triplicate samples. Error bars show SEM. b Summary table of cell proliferation data from (a)

Back to article page